Edward Kliphuis - Partner @ Sofinnova Partners

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Primary Job Title Partner
Primary Organization
Sofinnova Partners

Location Madrid, Madrid, Spain
Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn

Edward Gerrit Roelof Kliphuis is based out of Madrid, Madrid and is the Partner of Sofinnova Partners. Edward previously worked at M Ventures as a Investment Director. Edward Gerrit attended the Leiden University.

Personal Investments

Number of Investments

Edward Kliphuis

invested in

Padlock Therapeutics

obfuscation

. This investment -

Series A - Padlock Therapeutics

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Padlock Therapeutics	—	Series A - Padlock Therapeutics	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Excelsior Sciences	Sofinnova Partners	Yes	Series A - Excelsior Sciences	obfuscated obfuscation
obfuscated obfuscation	Latent Labs	Sofinnova Partners	Yes	Series A - Latent Labs	obfuscated obfuscation
obfuscated obfuscation	Bioptimus	Sofinnova Partners	—	Series A - Bioptimus	obfuscated obfuscation
obfuscated obfuscation	Bioptimus	Sofinnova Partners	Yes	Seed Round - Bioptimus	obfuscated obfuscation
obfuscated obfuscation	Betteromics	Sofinnova Partners	Yes	Series A - Betteromics	obfuscated obfuscation
obfuscated obfuscation	l'école	Sofinnova Partners	Yes	Seed Round - l'école	obfuscated obfuscation
obfuscated obfuscation	BioCorteX	Sofinnova Partners	Yes	Seed Round - BioCorteX	obfuscated obfuscation
obfuscated obfuscation	Kiro	Sofinnova Partners	Yes	Series A - Kiro	obfuscated obfuscation
obfuscated obfuscation	Wiliot	M Ventures	—	Series C - Wiliot	obfuscated obfuscation
obfuscated obfuscation	Akili Interactive Labs	M Ventures	—	Series D - Akili Interactive Labs	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

Edward Kliphuis

has

obfuscation

exit -

Padlock Therapeutics

Edward Kliphuis

has

obfuscation

exits. Their most notable exits are

Padlock Therapeutics

Padlock Therapeutics Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more.

Jobs

Number of Current Jobs

Number of Past Jobs

Edward Kliphuis

is the

Partner

Sofinnova Partners

. Additionally,

Edward Kliphuis

has had

past jobs including

Director

M Ventures

Sofinnova Partners PartnerJul 2021

Organization Name	Title At Company	Start Date	End Date
M Ventures	Director	Mar 2016	Sep 2021
Amadeus Capital Partners	Partner	Sep 2020	Jun 2021

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Edward Kliphuis

holds

board and advisor roles including

Board Member

Excelsior Sciences

Board Member

BioCorteX

, and

Board Member

Akili Interactive Labs

Excelsior Sciences Board MemberAug 2025
BioCorteX Board MemberMar 2023
Akili Interactive Labs Board Member
Bioptimus Board Member
Biolinq Board Member
Medisafe Board Member

Organization Name	Title At Company	Start Date	End Date
Wiliot	Board Member	—	Jun 2021

Related Hubs

Hub Name	CB Rank (Hub)
Finance Companies With Less Than $50M in Revenue (Top 10K)	3,420
Finance Private Equity Stage Companies With More Than 10 Employees	44,854
Asset Management Companies With Less Than $50M in Revenue (Top 10K)	6,603
Investors with Funds Raised in 2001	33,584
Europe, Middle East, and Africa (EMEA) Private Equity Stage Companies	22,560
Europe, Middle East, and Africa (EMEA) Private Equity Stage Companies With More Than 50 Employees	19,087
European Union (EU) Private Equity Stage Companies With More Than 50 Employees	28,859
Impact Investing Companies With More Than $1M in Revenue	16,884
Europe Venture Capital Investors	1,146
Late Stage Venture Investors with Investments in European Union (EU)	2,170